Spire Wealth Management Vista Gen Therapeutics, Inc. Transaction History

Spire Wealth Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$0.88 - $1.73 $352 - $692	-400 Reduced 40.0%	600 $1,000
Q1 2022 Apr 18, 2022	BUY	$1.14 - $2.09 $227 - $418	200 Added 25.0%	1,000 $1,000
Q4 2021 Jan 14, 2022	BUY	$1.67 - $2.76 $334 - $552	200 Added 33.33%	800 $2,000
Q3 2021 Oct 22, 2021	BUY	$2.62 - $3.45 $1,572 - $2,070	600 New	600 $2,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Spire Wealth Management with notifications on news.